Literature DB >> 27521518

Wounds that heal and wounds that don't - The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis.

Neal L Millar1, Charlotte O'Donnell2, Iain B McInnes1, Elizabeth Brint3.   

Abstract

IL-33 is a member of the IL-1 family of cytokines. IL-33 is predominantly located within the nucleus of cells where it plays a role in gene regulation. Given the right combination of signals and cellular damage, stored IL-33 is released from the cell where it can interact with its receptor ST2, triggering danger-associated responses and act as a cellular "alarmin". Whilst IL-33/ST2 signalling has been shown to induce potent pro-inflammatory responses that can be detrimental in certain disease states, a dichotomous, protective role of IL-33 in promoting wound healing has also emerged in multiple tissues types. This review will explore the current literature concerning this homeostatic role of IL-33/ST2 in tissue repair and also review its role in uncontrolled wound responses as seen in both fibrosis and tumorigenesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibrosis; Interleukin 33; ST2; Tissue damage; Tumorigenesis

Mesh:

Substances:

Year:  2016        PMID: 27521518     DOI: 10.1016/j.semcdb.2016.08.007

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  16 in total

Review 1.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

2.  Tollip Inhibits ST2 Signaling in Airway Epithelial Cells Exposed to Type 2 Cytokines and Rhinovirus.

Authors:  Azzeddine Dakhama; Reem Al Mubarak; Nicole Pavelka; Dennis Voelker; Max Seibold; Julie G Ledford; Monica Kraft; Liwu Li; Hong Wei Chu
Journal:  J Innate Immun       Date:  2019-03-29       Impact factor: 7.349

3.  H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition.

Authors:  Patrice Nancy; Johan Siewiera; Gabrielle Rizzuto; Elisa Tagliani; Ivan Osokine; Priyanka Manandhar; Igor Dolgalev; Caterina Clementi; Aristotelis Tsirigos; Adrian Erlebacher
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

4.  Interleukin-33 encourages scar formation in murine fetal skin wounds.

Authors:  Brian C Wulff; Nicholas K Pappa; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2018-11-23       Impact factor: 3.617

5.  Pleural Effusion IL-33/sST2 Levels and Effects of Low and High IL-33/sST2 Levels on Human Mesothelial Cell Adhesion and Migration.

Authors:  Ourania S Kotsiou; Rajesh M Jagirdar; Eleftherios D Papazoglou; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

6.  Interleukin-33 modulates inflammation in endometriosis.

Authors:  Jessica E Miller; Stephany P Monsanto; Soo Hyun Ahn; Kasra Khalaj; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

7.  Alerting the body to tissue injury: The role of alarmins and DAMPs in cutaneous wound healing.

Authors:  Traci A Wilgus
Journal:  Curr Pathobiol Rep       Date:  2018-01-20

Review 8.  The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.

Authors:  Mi-Ran Choi; Jeffrey A Sosman; Bin Zhang
Journal:  Cancers (Basel)       Date:  2021-06-30       Impact factor: 6.639

9.  Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Ruopeng Tan; Haixu Yu; Xu Han; Yang Liu; Xiaolei Yang; Yun-Long Xia; Xiaomeng Yin
Journal:  Front Cardiovasc Med       Date:  2021-06-17

Review 10.  The Role of IL-33/ST2 Pathway in Tumorigenesis.

Authors:  Kristen M Larsen; Maydelis Karla Minaya; Vivek Vaish; Maria Marjorette O Peña
Journal:  Int J Mol Sci       Date:  2018-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.